- Report
- January 2026
- 190 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 195 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 185 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 189 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 191 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 182 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 189 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 185 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- November 2025
- 191 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 198 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 190 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 369 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 193 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 194 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 199 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- September 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- September 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- September 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- September 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- April 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP

Sevoflurane is an anesthetic drug used in medical procedures to induce and maintain general anesthesia. It is a volatile anesthetic, meaning it is administered as a gas and is rapidly eliminated from the body. It is a halogenated ether, meaning it contains a halogen atom, such as fluorine, bonded to an ether molecule. It is a colorless, non-flammable liquid with a pleasant odor. It is commonly used in pediatric and adult patients for induction and maintenance of general anesthesia. It is also used in combination with other anesthetic drugs to provide balanced anesthesia.
Sevoflurane is a popular anesthetic drug due to its rapid onset and offset of action, low blood solubility, and low risk of toxicity. It is also relatively inexpensive compared to other anesthetic drugs.
Some companies in the sevoflurane market include Baxter International, AbbVie, Merck & Co., and Hospira. Show Less Read more